Blood glucose test strips are a central component of blood glucose measurement. These small, single-use plastic strips may look insignificant, but they play a very important role in helping people with diabetes monitor and control their diabetes.

Market Dynamics:

Increasing diabetes population, increasing obesity population, increasing demand for remote monitoring, emergence of new BGM technology, invasiveness associated with the use of test strip, increasing product launch and the outbreak of COVID-19 are major factors expected to augment growth of the global blood glucose test strip market over the forecast period.

For instance, in September 2020, LifeScan IP Holdings, LLC, a diagnostic systems manufacturer has announced the launch of its OneTouch Amazon store for people with type 1 and type 2 diabetes. The new web store includes the launch of a OneTouch Verio 30-strip test strip value pack that, along with nine other one touch-branded products, gives consumers access to its flagship product at a lower price

Key features of the study:

• This report provides in-depth analysis of the global blood glucose test strip market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global blood glucose test strip market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Abbott, F. Hoffmann-La Roche Ltd, Johnson & Johnson, ARKRAY, Inc., Ascensia Diabetes Care Holdings AG, AgaMatrix, Bionime Corporation, ACON Laboratories, Inc., MEDISANA GMBH, Tividia Health, Inc., Rossmax International Ltd., among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global blood glucose test strip market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood glucose test strip market.

Detailed Segmentation:

• Global Blood Glucose Test Strip Market, By Material Type:
  • Thin Film Electrochemical Films
  • Thick Film Electrochemical Films
  • Optical strips
• Global Blood Glucose Test Strip Market, By Technology:
  • Glucose Oxidase
  • Glucose Dehydrogenase
• Global Blood Glucose Test Strip Market, By Application:
  • Type I Diabetes
  • Type II Diabetes
• Global Blood Glucose Test Strip Market, By End User:
  • Hospitals
  • Home Care Settings
  • Diagnostic Laboratories
  • Others (Research and Academic Institutions, etc.)
• Global Blood Glucose Test Strip Market, By Geography:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa

• Company Profiles:
  • Abbott
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • AgaMatrix
  • Bionime Corporation
  • ACON Laboratories, Inc.
  • MEDISANA GMBH
  • Tividia Health, Inc.
  • Rossmax International Ltd.